Author

Abdullah Kharbosh

Observed names: Abdullah Mosa Kharbosh, Kharbosh, Abdullah

Institution: Taif University

Observed institutions: Princess Nourah bint Abdulrahman University, European Organisation for Research and Treatment of Cancer, Taif University, King Abdulaziz University, King Saud bin Abdulaziz University for Health Sciences, King Abdulaziz Medical City, European Organisation for Research and Treatment of Cancer

ORCID: 0000-0002-1389-5478

Observed ORCID: 0000-0002-1389-5478

OpenAlex ID: A5031949331

Evaluation of zinc sulfate as an adjunctive therapy in COVID-19 critically ill patients: a two center propensity-score matched study

2021 · Khalid Al Sulaiman, Ohoud Aljuhani, et al. · Critical Care · 35

The impact of HMG-CoA reductase inhibitors use on the clinical outcomes in critically ill patients with COVID-19: A multicenter, cohort study

2022 · Khalid Al Sulaiman, Ohoud Aljuhani, et al. · Frontiers in Public Health · 12

Single versus multiple doses of Tocilizumab in critically ill patients with coronavirus disease 2019 (COVID-19): A two-center, retrospective cohort study

2021 · Khalid Al Sulaiman, Ohoud Aljuhani, et al. · Journal of Critical Care · 12

Generic Substitutions and Therapeutic Interchanges in Hospital Pharmacies: A Qualitative Study from Western Saudi Arabia

2023 · Manar Hassan Alsufyani, Manayer Hammad Alghoribi, et al. · Healthcare · 10

Evaluation of Zinc Sulfate as an Adjunctive Therapy in COVID-19 Critically Ill Patients: a Two Center Propensity-score Matched Study

2021 · Khalid Al Sulaiman, Ohoud Al Juhani, et al. · Research Square · 10

The potential role of adjunctive ascorbic acid in the prevention of colistin-induced nephrotoxicity in critically ill patients: A retrospective study

2022 · Khalid Al Sulaiman, Ohoud Aljuhani, et al. · Saudi Pharmaceutical Journal · 6

Evolocumab safety and efficacy in hypercholesterolemia patients with or without diabetes: a retrospective real-world analysis

2025 · Sultan Ibrahim Alraddadi, Hind Almodaimegh, et al. · Diabetology & Metabolic Syndrome · 3

Impact of Ursodeoxycholic Acid in Critically Ill Patients With Sepsis: A Retrospective Study

2022 · Khalid Al Sulaiman, Abdullah Kharbosh, et al. · Journal of Pharmacy Practice · 3

Statins’ safety and impact on the clinical outcomes in COVID-19 critically ill patients: A Multicenter, Cohort Study

2021 · Khalid Al Sulaiman, Ohoud Aljuhani, et al. · Research Square · 1

Sociotechnical factors shaping patient acceptance of a national E-prescribing platform in Makkah Region, Saudi Arabia: A qualitative study

2026 · Mohammed S. Alharthi, Muath S. Althobaiti, et al. · Technology and Health Care

Comparison of the effectiveness and safety of enoxaparin vs. unfractionated heparin for venous thromboembolism (VTE) prophylaxis in critically ill medical patients

2022 · Khalid Al Sulaiman, Asma Alshehri, et al. · Saudi Journal of Clinical Pharmacy

Statins’ safety and impact on the clinical outcomes in COVID-19 critically ill patients: A Multicenter, Cohort Study

2021 · Khalid Al Sulaiman, Ohoud Aljuhani, et al. · Research Square

Statins’ safety and impact on the clinical outcomes in COVID-19 critically ill patients: A Multicenter, Cohort Study

2021 · Khalid Al Sulaiman1, Ohoud Aljuhani, et al. · Research Square

Works count: 17

Citation count: 92

H-index: 6

I10-index: 5